Morocco's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $1.30 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market will be driven by the rising frequency of chronic diseases, the requirement for improved diagnostic accuracy, and the availability of cutting-edge AI and machine learning technology. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Philips Healthcare.
Morocco's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $1.30 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Morocco, like many other nations, has a two-tiered medical system. The private medical system coexists alongside the universal public healthcare system. Since the public healthcare system is inadequate. According to WHO statistics published in 2020, the number of Coronary Heart Disease fatalities in Morocco reached 77,340, accounting for 33.89% of all deaths. Morocco ranked 19 in the world with an age-adjusted death rate of 242.07 per 100,000 inhabitants.
In Morocco, the adoption and utilization of AI diagnostics are still in their early phases, but there is rising anticipation of the potential of these technologies to enhance healthcare outcomes and boost efficiency. In Morocco, there are currently a few examples of AI being utilized in Diagnostics. A study team from the University of Hassan II in Casablanca has created an AI-powered system for the early diagnosis of diabetic retinopathy, a disease that can lead to blindness if unchecked. The device analyses retinal pictures using machine learning methods to identify indicators of the disorder with high accuracy. Furthermore, some Moroccan private businesses are investigating the application of AI diagnostics in fields such as cancer diagnosis, heart imaging, and telemedicine.
Market Growth Drivers
The Moroccan government has many multi-year plans to enhance the present health service, including the construction of additional hospitals, the recruitment of more doctors and nurses, and the liberalization of the market to private sector investment. Additionally, the increasing prevalence of chronic diseases, the increased need for more precise and effective diagnostic solutions, and the availability of cutting-edge information technology are expected to drive market expansion.
Market Restraints
In 2022, the public system would account for just 40% of healthcare spending, while the private sector would pay for 60%. The lack of standardized healthcare data is one of the most significant challenges. AI systems cannot be effectively trained without a trustworthy and consistent dataset. Furthermore, there may be privacy and security considerations that limit the sharing of healthcare data. Another issue is the lack of trained workers. AI algorithms necessitate the development and maintenance of trained individuals, and Morocco may confront a scarcity of experts with essential capabilities.
Key Players
The National Health Insurance Agency (Agence Nationale de l'Assurance Maladie, or ANAM) collaborates closely with the Moroccan Ministry of Health and the National Center for Science and Technological Research (Centre National de la Recherche Scientifique et Technique, or CNERST). CNERST is in charge of reviewing and certifying medical devices, including those that include AI technology, and ensuring that they fulfill the necessary safety and quality criteria.
The National Health Insurance Agency (Agence Nationale de l'Assurance Maladie, or ANAM) in Morocco is in charge of AI diagnostics reimbursement. ANAM is a government agency in charge of overseeing the country's mandated health insurance system, which covers more than 90% of the population. To be eligible for coverage in Morocco, an AI diagnosis must fulfill specific requirements defined by ANAM.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
The rising frequency of chronic diseases, the requirement for improved diagnostic accuracy, and the availability of cutting-edge AI and machine learning technology are the major drivers of Artificial Intelligence (AI) in the diagnostics market in Morocco.
IBM Watson Health, Siemens Healthineers, Philips Healthcare, GE Healthcare, United Imaging, Google Health, AliveCor, Inc, and Lunit Inc, are the major players of Artificial Intelligence (AI) in the diagnostics market in Morocco.
Artificial Intelligence (AI) in the diagnostics market in Morocco is segmented by component and by diagnosis.